Jennifer Neira
Nurse Practitioner · Oxnard, CANPI 1659792752
Payments from drug & device makers
Across 435 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Lilly USA, LLC$1K
- Novo Nordisk$942
- Astellas Pharma US Inc$894
- Amgen$821
- Boehringer Ingelheim$804
- plus $4K from 31 others
What the payments were for
- Food & beverage$9,53399%
- Education$1071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 64 | $1,410 |
| Lilly USA, LLC | 48 | $1,243 |
| Novo Nordisk | 47 | $942 |
| Astellas Pharma US Inc | 43 | $894 |
| Amgen | 36 | $821 |
| Boehringer Ingelheim | 35 | $804 |
| Pfizer | 33 | $692 |
| Bayer | 26 | $589 |
| GSK | 21 | $422 |
| Sanofi-aventis U.S. LLC | 12 | $292 |
| Mannkind Corporation | 9 | $194 |
| AbbVie | 9 | $167 |
| Johnson & Johnson | 7 | $107 |
| Revance Therapeutics, Inc. | 1 | $100 |
| Dexcom, Inc. | 3 | $84 |
| Radius Health, Inc. | 3 | $83 |
| Abbott | 4 | $77 |
| Amarin Pharma, Inc. | 4 | $66 |
| Novartis | 3 | $65 |
| Ardelyx, Inc. | 2 | $58 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Medicure Pharma Inc. | 2 | $49 |
| Idorsia Pharmaceuticals US Inc | 2 | $47 |
| Merck | 2 | $43 |
| Sanofi Pasteur Inc. | 2 | $41 |
| Exact Sciences | 2 | $35 |
| Medtronic | 1 | $34 |
| Corcept Therapeutics | 2 | $33 |
| Boston Scientific | 1 | $29 |
| Seqirus USA Inc | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Merz North America, Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,640 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 41 | $57,410 |
| OzempicSemaglutide | 32 | $32,447 |
| FarxigaDapagliflozin Propanediol | 26 | $27,836 |
| TrulicityDulaglutide | 15 | $18,814 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,864 |
| Ezetimibe | 80 | $1,519 |
| Atorvastatin Calcium | 194 | $1,135 |
| Levothyroxine Sodium | 67 | $983 |
| Ketoconazole | 55 | $944 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $869 |
| Olmesartan Medoxomil | 76 | $717 |
| SynthroidLevothyroxine Sodium | 15 | $592 |
| Metformin Hcl | 116 | $573 |
| Quetiapine Fumarate | 18 | $522 |
| Lisinopril | 77 | $458 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $804 | $57,41041 claims |
| Novo NordiskOzempic | $942 | $32,44732 claims |
| AstraZenecaFarxiga | $1,410 | $27,83626 claims |
| Lilly USA, LLCTrulicity | $1,243 | $18,81415 claims |
| AbbVieSynthroid | $167 | $59215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Oxnard
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.